Ultima-AOD9604 2mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE Anti-Obesity Drug-9604

For your peace of mind, products are shipped without brand labeling to ensure security.

AOD 9604 is a groundbreaking peptide derived from Growth Hormone, specifically crafted from the last 15 amino acids (176-191) of the Growth Hormone polypeptide. This unique formulation, also known as GH Frag 176-191, has quickly gained recognition as one of the most effective solutions for weight loss, delivering not only remarkable fat reduction but also enhanced metabolic function.

Stimulated Gland: Pituitary Gland

Key Benefits of AOD 9604:

• Significantly reduces body fat
• Facilitates the release of fat from obese fat cells more efficiently than from lean cells
• Mimics the natural fat metabolism regulation of growth hormone
• Maintains stable blood sugar levels without promoting growth
• Stimulates lipolysis (fat breakdown)
• Inhibits lipogenesis (conversion of food into body fat)
• Supports cartilage repair and regeneration, especially when combined with peptide BPC 157

How AOD 9604 Works:

AOD-9604, or Tyr-hGH Frag 176-191, is renowned for its exceptional fat-burning abilities without causing overeating. Unlike other treatments, it does not affect blood sugar levels or tissue growth. Instead, AOD-9604 activates the breakdown and oxidation of fat through a unique mechanism that operates independently of human growth hormone (hGH) receptors. Extensive research involving rodents, pigs, dogs, and humans has demonstrated that AOD-9604 effectively stimulates fat release from predominantly obese fat cells, curtails new fat accumulation, and accelerates fat burning?especially targeting stubborn abdominal fat.

While CJC-1295 is another potent fat loss peptide that increases overall GH levels, AOD-9604 stands out for its ability to promote fat loss without causing increased hunger or elevated cortisol levels, making it an ideal choice for those focused on shedding excess weight.

AOD 9604 Research:

Developed in the 1990s by Professor Frank Ng at Monash University, AOD-9604 was designed as an anti-obesity solution that harnesses the fat-burning advantages of human growth hormone (HGH) without stimulating muscle growth. Recent findings suggest that AOD 9604 not only supports fat loss but also offers regenerative properties associated with growth hormone. Ongoing clinical trials are investigating its potential for treating osteoarthritis, hypercholesterolemia, and aiding in the repair of bone and cartilage.

Results from oral glucose tolerance tests have shown that AOD 9604 does not negatively impact carbohydrate metabolism, unlike HGH. Importantly, no anti-AOD 9604 antibodies were detected in any evaluated patients, and there have been no reports of withdrawal or serious adverse effects associated with its use.

Conclusion:

AOD 9604 boasts an impressive safety and tolerability profile akin to that of a placebo, free from the side effects often linked with full-length hGH treatments. With its excellent safety record, AOD 9604 has recently attained Human GRAS status in the USA, making it a trustworthy option for those seeking effective weight loss solutions.